Here's how NATURE.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

NATURE . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Nature.com Make Money
  6. How Much Does Nature.com Make
  7. Keywords
  8. Topics
  9. Schema
  10. Social Networks
  11. External Links
  12. Analytics And Tracking
  13. Libraries
  14. Hosting Providers
  15. CDN Services

We are analyzing https://www.nature.com/articles/341755a0.

Title:
A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin | Nature
Description:
CYCLOSPORIN A and the newly discovered immunosuppressant, FK-506, are potent inhibitors of T cell activation1. In addition to their clinical importance in the prevention of allograft rejection, cyclosporin A and FK-506 represent important reagents for the study of the molecular mechanisms of lymphocyte activation. Cyclosporin A, a cyclic undecapeptide and FK-506, a macrolide, although chemically distinct, inhibit similar lymphocyte activation responses1, 2. The earliest responses inhibited in the T cell seem to be the expression of early phase T cell-activation genes for inter-leu kins 2, 3 and 4, granulocyte-macrophage colony stimulating factor and gamma interferon2–4. Although FK-506 and cyclosporin A seem to inhibit similar signal transduction processes, they do so by interacting with distinct cytosolic proteins5, 6. We report here the purification to homogeneity of a specific FK-506 binding protein that is distinct from the cyclosporin A-binding protein, cyclophilin7, 8. In addition, we show that this FK-506 binding protein, like cyclophilin, has peptidyl-prolyl isomerase activity9, 10.
Website Age:
30 years and 10 months (reg. 1994-08-11).

Matching Content Categories {📚}

  • Education
  • Social Networks
  • Telecommunications

Content Management System {📝}

What CMS is nature.com built with?

Custom-built

No common CMS systems were detected on Nature.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of nature.com audience?

🌆 Monumental Traffic: 20M - 50M visitors per month


Based on our best estimate, this website will receive around 44,058,289 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Nature.com Make Money? {💸}


Display Ads {🎯}


The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.

Ads are managed by yourbow.com. Particular relationships are as follows:

Direct Advertisers (10)
google.com, pmc.com, doceree.com, yourbow.com, audienciad.com, onlinemediasolutions.com, advibe.media, aps.amazon.com, getmediamx.com, onomagic.com

Reseller Advertisers (38)
conversantmedia.com, rubiconproject.com, pubmatic.com, appnexus.com, openx.com, smartadserver.com, lijit.com, sharethrough.com, video.unrulymedia.com, google.com, yahoo.com, triplelift.com, onetag.com, sonobi.com, contextweb.com, 33across.com, indexexchange.com, media.net, themediagrid.com, adform.com, richaudience.com, sovrn.com, improvedigital.com, freewheel.tv, smaato.com, yieldmo.com, amxrtb.com, adyoulike.com, adpone.com, criteo.com, smilewanted.com, 152media.info, e-planning.net, smartyads.com, loopme.com, opera.com, mediafuse.com, betweendigital.com

How Much Does Nature.com Make? {💰}


Display Ads {🎯}

$560,000 per month
Estimations show Nature.com's display ad online revenue falls between $370,132 and $1,017,862 per month.

Keywords {🔍}

article, nature, google, scholar, cas, access, content, ads, cookies, privacy, protein, activity, distinct, cyclophilin, cyclosporin, immun, research, data, binding, peptidylprolyl, siekierka, shirley, hung, cell, advertising, information, journal, subscribe, cytosolic, immunosuppressant, isomerase, poe, lin, sigal, activation, molecular, similar, institution, buy, open, september, usa, handschumacher, harding, permissions, scientific, function, optional, media, personal,

Topics {✒️}

nature portfolio permissions reprints dohme research laboratories privacy policy immunology research peptidyl-prolyl cis–trans isomerases advertising subscribe nature social media nature 337 nature 338 nature 341 nature peptidyl-prolyl isomerase activity9 slyd samuel pazickyanna-leoni peptidyl-prolyl isomerase activity cyclosporin a-binding protein personal data data protection springerlink instant access permissions molecular life sciences cell-activation genes privacy cytokine signaling activity cytokine secretion assay cytosolic binding protein explore content subscription content fk-506 binding protein european economic area earliest responses inhibited inter-leu kins 2 institutional subscriptions read shirley lin & nolan accepting optional cookies journals search log issue learn newly discovered immunosuppressant manage preferences genome-wide characterization article siekierka distinct cytosolic proteins5 content article purchase salt upregulated cyclophilin journal publish molecular mechanisms article cite lymphocyte activation

Schema {🗺️}

WebPage:
      mainEntity:
         headline:A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin
         description:CYCLOSPORIN A and the newly discovered immunosuppressant, FK-506, are potent inhibitors of T cell activation1. In addition to their clinical importance in the prevention of allograft rejection, cyclosporin A and FK-506 represent important reagents for the study of the molecular mechanisms of lymphocyte activation. Cyclosporin A, a cyclic undecapeptide and FK-506, a macrolide, although chemically distinct, inhibit similar lymphocyte activation responses1, 2. The earliest responses inhibited in the T cell seem to be the expression of early phase T cell-activation genes for inter-leu kins 2, 3 and 4, granulocyte-macrophage colony stimulating factor and gamma interferon2–4. Although FK-506 and cyclosporin A seem to inhibit similar signal transduction processes, they do so by interacting with distinct cytosolic proteins5, 6. We report here the purification to homogeneity of a specific FK-506 binding protein that is distinct from the cyclosporin A-binding protein, cyclophilin7, 8. In addition, we show that this FK-506 binding protein, like cyclophilin, has peptidyl-prolyl isomerase activity9, 10.
         datePublished:
         dateModified:
         pageStart:755
         pageEnd:757
         sameAs:https://doi.org/10.1038/341755a0
         keywords:
            Science
            Humanities and Social Sciences
            multidisciplinary
         image:
         isPartOf:
            name:Nature
            issn:
               1476-4687
               0028-0836
            volumeNumber:341
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Nature Publishing Group UK
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:John J. Siekierka
               affiliation:
                     name:Merck, Sharp and Dohme Research Laboratories
                     address:
                        name:Departments of Immunology Research and Enzymology, Merck, Sharp and Dohme Research Laboratories, Rahway, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Shirley H. Y. Hung
               affiliation:
                     name:Merck, Sharp and Dohme Research Laboratories
                     address:
                        name:Departments of Immunology Research and Enzymology, Merck, Sharp and Dohme Research Laboratories, Rahway, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Martin Poe
               affiliation:
                     name:Merck, Sharp and Dohme Research Laboratories
                     address:
                        name:Departments of Immunology Research and Enzymology, Merck, Sharp and Dohme Research Laboratories, Rahway, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:C. Shirley Lin
               affiliation:
                     name:Merck, Sharp and Dohme Research Laboratories
                     address:
                        name:Departments of Immunology Research and Enzymology, Merck, Sharp and Dohme Research Laboratories, Rahway, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Nolan H. Sigal
               affiliation:
                     name:Merck, Sharp and Dohme Research Laboratories
                     address:
                        name:Departments of Immunology Research and Enzymology, Merck, Sharp and Dohme Research Laboratories, Rahway, USA
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin
      description:CYCLOSPORIN A and the newly discovered immunosuppressant, FK-506, are potent inhibitors of T cell activation1. In addition to their clinical importance in the prevention of allograft rejection, cyclosporin A and FK-506 represent important reagents for the study of the molecular mechanisms of lymphocyte activation. Cyclosporin A, a cyclic undecapeptide and FK-506, a macrolide, although chemically distinct, inhibit similar lymphocyte activation responses1, 2. The earliest responses inhibited in the T cell seem to be the expression of early phase T cell-activation genes for inter-leu kins 2, 3 and 4, granulocyte-macrophage colony stimulating factor and gamma interferon2–4. Although FK-506 and cyclosporin A seem to inhibit similar signal transduction processes, they do so by interacting with distinct cytosolic proteins5, 6. We report here the purification to homogeneity of a specific FK-506 binding protein that is distinct from the cyclosporin A-binding protein, cyclophilin7, 8. In addition, we show that this FK-506 binding protein, like cyclophilin, has peptidyl-prolyl isomerase activity9, 10.
      datePublished:
      dateModified:
      pageStart:755
      pageEnd:757
      sameAs:https://doi.org/10.1038/341755a0
      keywords:
         Science
         Humanities and Social Sciences
         multidisciplinary
      image:
      isPartOf:
         name:Nature
         issn:
            1476-4687
            0028-0836
         volumeNumber:341
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Nature Publishing Group UK
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:John J. Siekierka
            affiliation:
                  name:Merck, Sharp and Dohme Research Laboratories
                  address:
                     name:Departments of Immunology Research and Enzymology, Merck, Sharp and Dohme Research Laboratories, Rahway, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Shirley H. Y. Hung
            affiliation:
                  name:Merck, Sharp and Dohme Research Laboratories
                  address:
                     name:Departments of Immunology Research and Enzymology, Merck, Sharp and Dohme Research Laboratories, Rahway, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Martin Poe
            affiliation:
                  name:Merck, Sharp and Dohme Research Laboratories
                  address:
                     name:Departments of Immunology Research and Enzymology, Merck, Sharp and Dohme Research Laboratories, Rahway, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:C. Shirley Lin
            affiliation:
                  name:Merck, Sharp and Dohme Research Laboratories
                  address:
                     name:Departments of Immunology Research and Enzymology, Merck, Sharp and Dohme Research Laboratories, Rahway, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Nolan H. Sigal
            affiliation:
                  name:Merck, Sharp and Dohme Research Laboratories
                  address:
                     name:Departments of Immunology Research and Enzymology, Merck, Sharp and Dohme Research Laboratories, Rahway, USA
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Nature
      issn:
         1476-4687
         0028-0836
      volumeNumber:341
Organization:
      name:Nature Publishing Group UK
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Merck, Sharp and Dohme Research Laboratories
      address:
         name:Departments of Immunology Research and Enzymology, Merck, Sharp and Dohme Research Laboratories, Rahway, USA
         type:PostalAddress
      name:Merck, Sharp and Dohme Research Laboratories
      address:
         name:Departments of Immunology Research and Enzymology, Merck, Sharp and Dohme Research Laboratories, Rahway, USA
         type:PostalAddress
      name:Merck, Sharp and Dohme Research Laboratories
      address:
         name:Departments of Immunology Research and Enzymology, Merck, Sharp and Dohme Research Laboratories, Rahway, USA
         type:PostalAddress
      name:Merck, Sharp and Dohme Research Laboratories
      address:
         name:Departments of Immunology Research and Enzymology, Merck, Sharp and Dohme Research Laboratories, Rahway, USA
         type:PostalAddress
      name:Merck, Sharp and Dohme Research Laboratories
      address:
         name:Departments of Immunology Research and Enzymology, Merck, Sharp and Dohme Research Laboratories, Rahway, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:John J. Siekierka
      affiliation:
            name:Merck, Sharp and Dohme Research Laboratories
            address:
               name:Departments of Immunology Research and Enzymology, Merck, Sharp and Dohme Research Laboratories, Rahway, USA
               type:PostalAddress
            type:Organization
      name:Shirley H. Y. Hung
      affiliation:
            name:Merck, Sharp and Dohme Research Laboratories
            address:
               name:Departments of Immunology Research and Enzymology, Merck, Sharp and Dohme Research Laboratories, Rahway, USA
               type:PostalAddress
            type:Organization
      name:Martin Poe
      affiliation:
            name:Merck, Sharp and Dohme Research Laboratories
            address:
               name:Departments of Immunology Research and Enzymology, Merck, Sharp and Dohme Research Laboratories, Rahway, USA
               type:PostalAddress
            type:Organization
      name:C. Shirley Lin
      affiliation:
            name:Merck, Sharp and Dohme Research Laboratories
            address:
               name:Departments of Immunology Research and Enzymology, Merck, Sharp and Dohme Research Laboratories, Rahway, USA
               type:PostalAddress
            type:Organization
      name:Nolan H. Sigal
      affiliation:
            name:Merck, Sharp and Dohme Research Laboratories
            address:
               name:Departments of Immunology Research and Enzymology, Merck, Sharp and Dohme Research Laboratories, Rahway, USA
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Departments of Immunology Research and Enzymology, Merck, Sharp and Dohme Research Laboratories, Rahway, USA
      name:Departments of Immunology Research and Enzymology, Merck, Sharp and Dohme Research Laboratories, Rahway, USA
      name:Departments of Immunology Research and Enzymology, Merck, Sharp and Dohme Research Laboratories, Rahway, USA
      name:Departments of Immunology Research and Enzymology, Merck, Sharp and Dohme Research Laboratories, Rahway, USA
      name:Departments of Immunology Research and Enzymology, Merck, Sharp and Dohme Research Laboratories, Rahway, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(64)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Prism.js
  • Zoom.js

Emails and Hosting {✉️}

Mail Servers:

  • mxa-002c5801.gslb.pphosted.com
  • mxb-002c5801.gslb.pphosted.com

Name Servers:

  • pdns1.ultradns.net
  • pdns2.ultradns.net
  • pdns3.ultradns.org
  • pdns4.ultradns.org
  • pdns5.ultradns.info
  • pdns6.ultradns.co.uk

CDN Services {📦}

  • Crossref

7.68s.